KOSDAQ - Delayed Quote KRW

3billion (394800.KQ)

6,500.00
-150.00
(-2.26%)
At close: May 23 at 3:30:16 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
5,772,098.14
2,730,329.27
828,460.80
550,658.68
Gross Profit
6,846,812.42
5,772,098.14
2,730,329.27
828,460.80
550,658.68
Operating Expense
13,091,532
13,091,532
11,082,602
9,052,456
7,248,745
Operating Income
-7,319,433.86
-7,319,433.86
-8,352,272.73
-8,223,995.20
-6,698,086.32
Net Non Operating Interest Income Expense
389,611.76
440,767.72
2,640,521.09
4,341,232.58
716,083.07
Pretax Income
-6,505,427.57
-6,571,645.54
-5,092,006.70
-3,144,811.17
-59,104,789.90
Net Income Common Stockholders
-6,505,427.57
-6,571,645.54
-5,092,006.70
-3,144,811.17
-59,104,789.90
Basic EPS
-219.00
--
-201.00
-127.00
-4.44k
Diluted EPS
-219.00
--
-257.00
-257.00
-4.44k
Basic Average Shares
29,561.41
28,083.96
25,333.37
24,762.29
13,311.89
Diluted Average Shares
28,083.96
28,083.96
19,813.26
12,236.62
13,311.89
Total Operating Income as Reported
-7,419,089.16
-7,419,089.16
-8,352,273.04
-8,223,995.67
-6,698,086.01
Total Expenses
14,187,868
13,091,532
11,082,602
9,052,456
7,248,745
Net Income from Continuing & Discontinued Operation
-6,571,645.54
-6,571,645.54
-5,092,006.70
-3,144,811.17
-59,104,789.90
Normalized Income
-6,965,290.57
-7,031,508.54
-5,092,006.70
-3,144,811.17
-59,104,789.90
Interest Income
343,845
350,884
622,733
391,382
128,246
Interest Expense
68,702
24,585
63,411
25,935
30,611
Net Interest Income
440,767.72
440,767.72
2,640,521.09
4,341,232.58
716,083.07
EBIT
--
-6,547,060.54
-5,028,595.70
-3,118,876.17
-59,074,178.90
EBITDA
-4,969,551.57
-4,863,244.54
-3,602,636.70
-2,168,478.17
-58,313,645.90
Reconciled Depreciation
1,467,174
1,683,816
1,425,959
950,398
760,533
Net Income from Continuing Operation Net Minority Interest
--
-6,571,645.54
-5,092,006.70
-3,144,811.17
-59,104,789.90
Total Unusual Items Excluding Goodwill
459,863
459,863
--
--
--
Total Unusual Items
459,863
459,863
--
--
--
Normalized EBITDA
-5,429,414.57
-5,323,107.54
-3,602,636.70
-2,168,478.17
-58,313,645.90
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
0
0
0
0
12/31/2021 - 11/14/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
68.10
-0.42%
 
002287.SZ Tibet Cheezheng Tibetan Medicine Co., Ltd.
24.46
+0.45%
 
688331.SS RemeGen Co., Ltd.
57.83
+2.08%
 
087010.KQ Peptron, Inc.
220,000.00
+5.01%
 
476040.KQ ORGANOIDSCIENCES
40,950.00
-10.10%
 
2162.HK Keymed Biosciences Inc.
40.300
-0.98%
 
1952.HK Everest Medicines Limited
42.700
-1.39%
 
6660.HK AIM Vaccine Co., Ltd.
4.060
-2.17%
 
2171.HK CARsgen Therapeutics Holdings Limited
20.400
-10.13%
 
2142.HK HBM Holdings Limited
8.810
-3.72%